Follow
Dr. Michael Schnekenburger, PhD
Dr. Michael Schnekenburger, PhD
Research group leader-LBMCC, Luxembourg, Luxembourg
Verified email at lbmcc.lu
Title
Cited by
Cited by
Year
Chemopreventive and therapeutic effects of curcumin
A Duvoix, R Blasius, S Delhalle, M Schnekenburger, F Morceau, E Henry, ...
Cancer letters 223 (2), 181-190, 2005
11632005
Long term low-dose arsenic exposure induces loss of DNA methylation
JF Reichard, M Schnekenburger, A Puga
Biochemical and biophysical research communications 352 (1), 188-192, 2007
3482007
Histone deacetylase 6 in health and disease
C Seidel, M Schnekenburger, M Dicato, M Diederich
Epigenomics 7 (1), 103-118, 2015
2192015
Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition
A Duvoix, F Morceau, S Delhalle, M Schmitz, M Schnekenburger, ...
Biochemical pharmacology 66 (8), 1475-1483, 2003
1852003
Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation
M Schnekenburger, G Talaska, A Puga
Molecular and cellular biology 27 (20), 7089-7101, 2007
1622007
HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation
M Schnekenburger, L Peng, A Puga
Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1769 (9-10 …, 2007
1422007
Epigenomics of leukemia: from mechanisms to therapeutic applications
C Florean, M Schnekenburger, C Grandjenette, M Dicato, M Diederich
Epigenomics 3 (5), 581-609, 2011
1322011
Plant-derived epigenetic modulators for cancer treatment and prevention
M Schnekenburger, M Dicato, M Diederich
Biotechnology advances 32 (6), 1123-1132, 2014
1282014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells
S Valente, Y Liu, M Schnekenburger, C Zwergel, S Cosconati, C Gros, ...
Journal of medicinal chemistry 57 (3), 701-713, 2014
1252014
Epigenetics offer new horizons for colorectal cancer prevention
M Schnekenburger, M Diederich
Current colorectal cancer reports 8 (1), 66-81, 2012
1222012
An introduction to the molecular mechanisms of apoptosis
S Delhalle, A Duvoix, M Schnekenburger, F Morceau, M Dicato, ...
Annals of the New York Academy of Sciences 1010 (1), 1-8, 2003
1162003
Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs
MA Sartor, M Schnekenburger, JL Marlowe, JF Reichard, Y Wang, Y Fan, ...
Environmental Health Perspectives 117 (7), 1139-1146, 2009
1142009
Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis
M Schnekenburger, T Karius, M Diederich
Frontiers in pharmacology 5, 99224, 2014
1102014
Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence …
M Schnekenburger, C Grandjenette, J Ghelfi, T Karius, B Foliguet, ...
Biochemical pharmacology 81 (3), 364-378, 2011
1102011
Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition
A Duvoix, S Delhalle, R Blasius, M Schnekenburger, F Morceau, ...
Biochemical pharmacology 68 (6), 1101-1111, 2004
1082004
Protein Kinase and HDAC Inhibitors from the Endophytic Fungus Epicoccum nigrum
M El Amrani, D Lai, A Debbab, AH Aly, K Siems, C Seidel, ...
Journal of natural products 77 (1), 49-56, 2014
1072014
Natural chalcones as dual inhibitors of HDACs and NF-κB
B Orlikova, M Schnekenburger, M Zloh, F Golais, M Diederich, ...
Oncology reports 28 (3), 797-805, 2012
1022012
UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells
T Juncker, C Cerella, MH Teiten, F Morceau, M Schumacher, J Ghelfi, ...
Biochemical pharmacology 81 (1), 13-23, 2011
972011
4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer
C Seidel, M Schnekenburger, A Mazumder, MH Teiten, G Kirsch, M Dicato, ...
Biochemical pharmacology 99, 31-52, 2016
942016
Chromatin-modifying agents in anti-cancer therapy
C Seidel, C Florean, M Schnekenburger, M Dicato, M Diederich
Biochimie 94 (11), 2264-2279, 2012
932012
The system can't perform the operation now. Try again later.
Articles 1–20